Clinical burden of acute respiratory infections in children < 5 years in the emergency room: results from the first season (2023/24) of the RISE study - Takeaways - MDSpire

Clinical burden of acute respiratory infections in children < 5 years in the emergency room: results from the first season (2023/24) of the RISE study

  • By

  • Vivien Greese

  • Tamina Schenck

  • Maria Adams

  • Eva Jenz

  • Marti Juanola-Falgarona

  • Annika Wülfing

  • Christine Hagemann

  • Tobias Tenenbaum

  • February 15, 2026

  • 0 min

Share

  • 1

    Acute respiratory infections (ARI) are a significant cause of emergency room visits and hospitalizations in children under 5 years.

  • 2

    Respiratory syncytial virus (RSV), rhinovirus, and influenza are common viral pathogens responsible for ARI in young children.

  • 3

    The RISE study aims to analyze ER attendance and hospitalization rates for ARI in children under 5 during the 2023/2024 winter season.

  • 4

    Multiplex real-time PCR testing is utilized to identify specific respiratory pathogens in children presenting with ARI symptoms.

  • 5

    Data collection in the RISE study includes socio-demographic, clinical, and laboratory findings to assess the burden of ARI in the pediatric population.

Original Source(s)

Clinical burden of acute respiratory infections in children < 5 years in the emergency room: results from the first season (2023/24) of the RISE study

  • by Vivien Greese, Tamina Schenck, Maria Adams, Eva Jenz, Marti Juanola-Falgarona, Annika Wülfing, Christine Hagemann, Tobias Tenenbaum

  • February 15, 2026

Related Content

Advancements in Intranasal Influenza Vaccines: Mechanisms, Platforms, and Progress in Translation

Prevalence and determinants of fever, diarrhea, and acute respiratory infection among children aged 5–59 months in Somaliland, 2020: insights from a nationwide survey

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.